Citi's Fixed Income team initiated coverage Teva Pharma (NYSE: TEVA) debt with an Underweight rating, citing a lack of positive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE